Pharma Co. Amarin Beats Class Action Over Patent Issues

By Katryna Perera · September 27, 2024, 6:44 PM EDT

A New Jersey federal judge has tossed a proposed class action against pharmaceutical company Amarin and its top brass, alleging they misled shareholders about their products and the prospects of related...

To view the full article, register now.

Documents

Case Information

Case Title

DANG v. AMARIN CORPORATION PLC et al

Case Number

3:21-cv-19212

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

October 21, 2021